Columns - BioPharm International

ADVERTISEMENT

Columns
Operational Excellence Series
Outsourcing Insights

Various contributors provide best business practices and insights into achieving operational excellence.

View Articles


Regulatory Beat
Regulatory Beat

Jill Wechsler tracks the decisions made on Capitol Hill and at FDA, and reports on significant regulatory decisions and policy developments.

View Articles


Best Practices
BestPractices

Simon Chalk of the BioPhorum Operations Group tackles current and growing industry thoughts on common manufacturing challenges. In addition, experts offer best analytical practices with the aim of meeting regulatory expectations.
Manufacturing Articles
Analytical Articles


The Disposables Advisor
The Disposables Advisor

Jerold Martin offers helpful guidance and examples of what other companies have learned from their experiences implementing disposables.

View Articles


Compliance Notes
Compliance Notes

Senior experts from Tunnell Consulting offer insight into applying concepts such as QbD, and help readers decipher new FDA guidance documents.

View Articles

View past columns

China Today
India Today
Outsourcing Insights (now perspectives on Outsourcing)
Street Talk

 

Final Word
Final Word

Industry experts and consultants offer perspectives on hot topics and trends in biopharmaceutical development and manufacturing.

View Articles


From The Editor
From The Editor

Editorial Director Rita Peters and guest editors, provide perspective on industry developments.

View Articles


Basic Training: Business & Tech Guides
Boot Camp

Aimed at biotech companies moving from discovery into development, the series offers a boot-camp approach to bioprocessing steps and business development.
View Business Guides
View Tech Guides


Perspectives on Outsourcing
Perspectives on Outsourcing

Experts provide industry analysis and insight into outsourcing trends to help outsourcing decision-makers. Featuring experts Jim Miller and Eric Langer.

View Articles


Burrill on Biotech
Burrill on Biotech

G. Steven Burrill assesses and projects developments in venture capital, M&As, and the overall partnering environment.

View Articles

 

ADVERTISEMENT

ADVERTISEMENT

Click here